Market Cap 9.40B
Revenue (ttm) 3.24B
Net Income (ttm) -3.56B
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -110.04%
Debt to Equity Ratio 0.00
Volume 16,526,400
Avg Vol 10,553,334
Day's Range N/A - N/A
Shares Out 390.73M
Stochastic %K 85%
Beta 1.11
Analysts Sell
Price Target $35.68

Company Profile

Moderna, Inc., a biotechnology company, provides messenger RNA medicines in the United States, Europe, and internationally. The company's respiratory vaccines include spikevax, mRESVIA, COVID, RSV, seasonal influenza, combination, and pandemic influenza vaccine; latent vaccines comprise cytomegalovirus, epstein-barr virus, herpes simplex virus, varicella zoster virus, and human immunodeficiency virus vaccines; enteric viruses include norovirus; public health vaccines consist of Zika, Nipah, and...

Industry: Biotechnology
Sector: Healthcare
Phone: 617 714 6500
Address:
325 Binney Street, Cambridge, United States
Fook_Mi
Fook_Mi Dec. 6 at 1:06 AM
$MRNA wow someone bought a ton at end of day right? ({high of day}) - lookin funkin good
0 · Reply
History101
History101 Dec. 6 at 12:08 AM
$MRNA LOL. Hundreds of studies worldwide have shown the health hazards of the mrna covid shots, and one single study from france shows how "healthy" the shots are? Was this study paid for by big pharma & performed by a bunch of mrna & pfe "scientists"?? I am confident that once this study is reviewed by truly independent scientists & statisticians, the mrna covid shots will be shown to be as dangerous as has been clearly shown in all other legit studies. LOL.
1 · Reply
IOIOKJK
IOIOKJK Dec. 5 at 11:38 PM
$NIO https://www.linkedin.com/posts/lydia-brown-4b1402399_%F0%9D%99%85%F0%9D%99%A4%F0%9D%99%9E%F0%9D%99%A3-%F0%9D%99%A4%F0%9D%99%AA%F0%9D%99%A7-%F0%9D%99%92%F0%9D%99%9D%F0%9D%99%96%F0%9D%99%A9-%F0%9D%99%A8%F0%9D%98%BC%F0%9D%99%A5%F0%9D%99%A5-%F0%9D%99%9C%F0%9D%99%A7%F0%9D%99%A4%F0%9D%99%AA%F0%9D%99%A5-activity-7402825850246606848-_YCW?utm_source=share&utm_medium=member_desktop&rcm=ACoAAGHFEEUBFgTJgzVmWE-7CSCrmtiABJA6FFg $MRNA $HOLO
0 · Reply
ddsmda
ddsmda Dec. 5 at 11:25 PM
$MRNA not only 75% less likely from Covid but also 25% from dying from any other disease . Tell this to the jfk jr and other so called experts with no medical qualification
0 · Reply
ChangeisNewConstant
ChangeisNewConstant Dec. 5 at 11:20 PM
0 · Reply
ddsmda
ddsmda Dec. 5 at 11:18 PM
0 · Reply
ddsmda
ddsmda Dec. 5 at 11:16 PM
0 · Reply
taxplanr
taxplanr Dec. 5 at 10:26 PM
malignantRNA C19 jabs to receive Death Warning $BNTX $MRNA $PFE https://www.instagram.com/reel/DR2ILuZEXdW/?igsh=MXdkaTd2YmRieHd4ZQ==
0 · Reply
taxplanr
taxplanr Dec. 5 at 10:21 PM
FDA C19 jab deaths investigation $BNTX $MRNA $PFE https://www.lifesitenews.com/news/father-grateful-to-fda-for-acknowledging-son-was-killed-by-covid-jab/
0 · Reply
PrivateProfiteersAnalyst
PrivateProfiteersAnalyst Dec. 5 at 10:04 PM
Actionable Trade Alert for $MRNA: Market Context: $MRNA is currently trading at $25.49, showing a neutral RSI of 52.68, indicating no immediate overbought or oversold conditions. The stock is positioned between its 60D high of $29.45 and low of $22.28, suggesting potential for upward movement. Directional Bias: The price is above the 30-day moving average (MA30) of $25.08 but below the 50-day moving average (MA50) of $25.79. This indicates a potential bullish reversal as it approaches the MA50. The ATR of 1.24 suggests moderate volatility, allowing for reasonable price movement. Trade Plan: - Suggested Entry: $25.50 - Stop Loss: $24.50 (1.00 below entry) - Take Profit Targets: - Target 1: $27.00 (5.88% ROI) - Target 2: $28.00 (9.53% ROI) - Target 3: $29.00 (13.56% ROI) To achieve at least a 17% ROI, consider a longer timeframe for Target 3, aligning with the 60D high. For more insights, visit https://privateprofiteers.com. https://privateprofiteers.com
0 · Reply
Latest News on MRNA
Moderna, Inc. (MRNA) Analyst/Investor Day Transcript

Nov 24, 2025, 8:03 PM EST - 11 days ago

Moderna, Inc. (MRNA) Analyst/Investor Day Transcript


What Is Going On With Moderna Stock?

Nov 13, 2025, 9:25 AM EST - 22 days ago

What Is Going On With Moderna Stock?


Moderna, Inc. (MRNA) Q3 2025 Earnings Call Transcript

Nov 6, 2025, 3:26 PM EST - 4 weeks ago

Moderna, Inc. (MRNA) Q3 2025 Earnings Call Transcript


Moderna Swings to a Loss on Fewer Covid-19 Vaccine Sales

Nov 6, 2025, 7:09 AM EST - 4 weeks ago

Moderna Swings to a Loss on Fewer Covid-19 Vaccine Sales


Moderna Stock Is Sliding Monday: What's Going On?

Nov 3, 2025, 3:54 PM EST - 4 weeks ago

Moderna Stock Is Sliding Monday: What's Going On?


Moderna: Focus On Cancer Vaccines, Not Buyout

Oct 31, 2025, 4:05 PM EDT - 5 weeks ago

Moderna: Focus On Cancer Vaccines, Not Buyout


Moderna (MRNA) Stock Is Trading Lower Friday: What's Going On?

Oct 31, 2025, 3:57 PM EDT - 5 weeks ago

Moderna (MRNA) Stock Is Trading Lower Friday: What's Going On?


Moderna to Host Investor Event - Analyst Day

Oct 23, 2025, 7:00 AM EDT - 6 weeks ago

Moderna to Host Investor Event - Analyst Day


Moderna ends development of CMV vaccine after trial failure

Oct 22, 2025, 4:34 PM EDT - 6 weeks ago

Moderna ends development of CMV vaccine after trial failure


Should You Buy Moderna Right Now?

Oct 22, 2025, 9:53 AM EDT - 6 weeks ago

Should You Buy Moderna Right Now?


Moderna Vs BioNTech: Who's Winning The Post-COVID Race

Oct 18, 2025, 9:30 AM EDT - 6 weeks ago

Moderna Vs BioNTech: Who's Winning The Post-COVID Race

BNTX


Moderna, Inc. (MRNA) Shareholder/Analyst Call Transcript

Oct 17, 2025, 4:06 PM EDT - 7 weeks ago

Moderna, Inc. (MRNA) Shareholder/Analyst Call Transcript


Why Moderna Might Be a One-Hit Wonder

Oct 15, 2025, 4:08 PM EDT - 7 weeks ago

Why Moderna Might Be a One-Hit Wonder


2 Beaten-Down Stocks to Buy and Hold for a Decade

Sep 30, 2025, 7:30 AM EDT - 2 months ago

2 Beaten-Down Stocks to Buy and Hold for a Decade

REGN


3 Of My Favorite Biotech Stocks Under $10

Sep 29, 2025, 1:15 PM EDT - 2 months ago

3 Of My Favorite Biotech Stocks Under $10

DVAX FOLD NUVB PFE


Fook_Mi
Fook_Mi Dec. 6 at 1:06 AM
$MRNA wow someone bought a ton at end of day right? ({high of day}) - lookin funkin good
0 · Reply
History101
History101 Dec. 6 at 12:08 AM
$MRNA LOL. Hundreds of studies worldwide have shown the health hazards of the mrna covid shots, and one single study from france shows how "healthy" the shots are? Was this study paid for by big pharma & performed by a bunch of mrna & pfe "scientists"?? I am confident that once this study is reviewed by truly independent scientists & statisticians, the mrna covid shots will be shown to be as dangerous as has been clearly shown in all other legit studies. LOL.
1 · Reply
IOIOKJK
IOIOKJK Dec. 5 at 11:38 PM
$NIO https://www.linkedin.com/posts/lydia-brown-4b1402399_%F0%9D%99%85%F0%9D%99%A4%F0%9D%99%9E%F0%9D%99%A3-%F0%9D%99%A4%F0%9D%99%AA%F0%9D%99%A7-%F0%9D%99%92%F0%9D%99%9D%F0%9D%99%96%F0%9D%99%A9-%F0%9D%99%A8%F0%9D%98%BC%F0%9D%99%A5%F0%9D%99%A5-%F0%9D%99%9C%F0%9D%99%A7%F0%9D%99%A4%F0%9D%99%AA%F0%9D%99%A5-activity-7402825850246606848-_YCW?utm_source=share&utm_medium=member_desktop&rcm=ACoAAGHFEEUBFgTJgzVmWE-7CSCrmtiABJA6FFg $MRNA $HOLO
0 · Reply
ddsmda
ddsmda Dec. 5 at 11:25 PM
$MRNA not only 75% less likely from Covid but also 25% from dying from any other disease . Tell this to the jfk jr and other so called experts with no medical qualification
0 · Reply
ChangeisNewConstant
ChangeisNewConstant Dec. 5 at 11:20 PM
0 · Reply
ddsmda
ddsmda Dec. 5 at 11:18 PM
0 · Reply
ddsmda
ddsmda Dec. 5 at 11:16 PM
0 · Reply
taxplanr
taxplanr Dec. 5 at 10:26 PM
malignantRNA C19 jabs to receive Death Warning $BNTX $MRNA $PFE https://www.instagram.com/reel/DR2ILuZEXdW/?igsh=MXdkaTd2YmRieHd4ZQ==
0 · Reply
taxplanr
taxplanr Dec. 5 at 10:21 PM
FDA C19 jab deaths investigation $BNTX $MRNA $PFE https://www.lifesitenews.com/news/father-grateful-to-fda-for-acknowledging-son-was-killed-by-covid-jab/
0 · Reply
PrivateProfiteersAnalyst
PrivateProfiteersAnalyst Dec. 5 at 10:04 PM
Actionable Trade Alert for $MRNA: Market Context: $MRNA is currently trading at $25.49, showing a neutral RSI of 52.68, indicating no immediate overbought or oversold conditions. The stock is positioned between its 60D high of $29.45 and low of $22.28, suggesting potential for upward movement. Directional Bias: The price is above the 30-day moving average (MA30) of $25.08 but below the 50-day moving average (MA50) of $25.79. This indicates a potential bullish reversal as it approaches the MA50. The ATR of 1.24 suggests moderate volatility, allowing for reasonable price movement. Trade Plan: - Suggested Entry: $25.50 - Stop Loss: $24.50 (1.00 below entry) - Take Profit Targets: - Target 1: $27.00 (5.88% ROI) - Target 2: $28.00 (9.53% ROI) - Target 3: $29.00 (13.56% ROI) To achieve at least a 17% ROI, consider a longer timeframe for Target 3, aligning with the 60D high. For more insights, visit https://privateprofiteers.com. https://privateprofiteers.com
0 · Reply
long_term_vision
long_term_vision Dec. 5 at 9:33 PM
$MRNA https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2842305
0 · Reply
Jamolo
Jamolo Dec. 5 at 9:12 PM
0 · Reply
THE_Monkey_Banana_Genius
THE_Monkey_Banana_Genius Dec. 5 at 9:08 PM
$MRNA huge volume into the close. 👀
0 · Reply
TradeTherapyLLC
TradeTherapyLLC Dec. 5 at 8:49 PM
Everyone remembers the $MRNA moonshot. Very few remember the distribution. In 2022 the monthly chart printed a textbook top: head and shoulders structure, back-to-back evening stars, and small bodied, high volume candles as institutions quietly sold into every late buyer. This week’s Clarity walks through how that pattern led into a full markdown and what it tells us about the base MRNA has built now.
1 · Reply
PeacefulOne
PeacefulOne Dec. 5 at 8:45 PM
$MRNA sold $165 put -> collected $13.8K -> getting 100 shares on 1/16
0 · Reply
Kat156
Kat156 Dec. 5 at 8:36 PM
$MRNA Shares of biotechnology company Moderna (NASDAQ:MRNA) jumped 6.4% in the afternoon session after a major long-term study from France indicated that its COVID-19 vaccine was safe and effective. The nationwide study, which was the first of its kind to look at long-term risk, analyzed data from approximately 28 million people. Researchers found that individuals who received the Moderna or Pfizer vaccine had a roughly 75% lower risk of dying from COVID compared to those who were unvaccinated. The study also revealed a 25% lower risk of death from any cause for the vaccinated group. These results provided strong evidence for the long-term safety of the mRNA vaccines, reassuring investors about the company's key product.
0 · Reply
DrSammy
DrSammy Dec. 5 at 8:27 PM
$MRNA Beautiful :)
0 · Reply
ThizzMarkie
ThizzMarkie Dec. 5 at 8:25 PM
$MRNA Up based on long term study of 28 million people showing MRNA vaccine lowered all cause mortality by 25%. Thats nuts. Basically If you took mrna vax, your 25% less likely to die from anything.
1 · Reply
Kat156
Kat156 Dec. 5 at 8:21 PM
$MRNA https://www.theglobeandmail.com/investing/markets/stocks/MRNA/pressreleases/36482287/why-is-moderna-mrna-stock-rocketing-higher-today/
0 · Reply
RodTownsend
RodTownsend Dec. 5 at 8:18 PM
$MRNA in a tight coil where quiet accumulation could flip into momentum if volume reappears
1 · Reply
SonicPricers
SonicPricers Dec. 5 at 8:10 PM
Gotta give it to @Invinc1ble dude’s been on a hot streak 🔥 Worth a follow! $GME $MRNA $SUGP $QS Additional
0 · Reply
jedrzejjj10
jedrzejjj10 Dec. 5 at 8:07 PM
$MRNA Almost a year of accumulation. A few bullish divergences on 1T. Nice rising RSI, 3x volume. Looks like a bottom. Very good R\R. Send it
0 · Reply